B. Oyan Et Al. , "High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)," 46th Annual Meeting of the American-Society-of-Hematology , vol.104, California, United States Of America, 2004
Oyan, B. Et Al. 2004. High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). 46th Annual Meeting of the American-Society-of-Hematology , (California, United States Of America).
Oyan, B., Koc, Y., Ozdemir, E., & Kansu, E., (2004). High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) . 46th Annual Meeting of the American-Society-of-Hematology, California, United States Of America
Oyan, BAŞAK Et Al. "High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)," 46th Annual Meeting of the American-Society-of-Hematology, California, United States Of America, 2004
Oyan, BAŞAK O. Et Al. "High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)." 46th Annual Meeting of the American-Society-of-Hematology , California, United States Of America, 2004
Oyan, B. Et Al. (2004) . "High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)." 46th Annual Meeting of the American-Society-of-Hematology , California, United States Of America.
@conferencepaper{conferencepaper, author={BAŞAK OYAN ULUÇ Et Al. }, title={High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)}, congress name={46th Annual Meeting of the American-Society-of-Hematology}, city={California}, country={United States Of America}, year={2004}}